Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Cancer Immunotherapy Market: By Therapy Type: Monoclonal Antibodies, Cancer Vaccines, Immunomodulators, Immune Check Point Inhibitors, Others; By Application; By End Use; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics; Value Chain Analysis; Competitive Landscape; Industry Events and Developments
Global Cancer Immunotherapy Market Outlook
The global cancer immunotherapy market stood at a value of around USD 86,607 million in 2020. The market is further expected to grow at a CAGR of 9.7% in the forecast period of 2023-2028 to attain a value of USD 1,50,523 million by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Demand for Monoclonal Antibodies to Catalyse the Growth of the Global Cancer Immunotherapy Industry
Based on therapy type, the monoclonal antibodies segment is expected to hold a significant share in the global cancer immunotherapy industry during the forecast period. This growth can be attributed to the heightened implementation of monoclonal antibodies therapy in cancer treatment globally. Monoclonal antibodies are immune system proteins created in the lab. Antibodies help the immune system to identify disease-causing bacteria and viruses and target them. For example, rituximab binds to a protein called CD20 on B cells, a type of white blood cells, and some types of cancer cells, causing the immune system to attack them. These factors are estimated to drive the market growth in the forecast period.
North America to Possess a Substantial Market Share in the Global Cancer Immunotherapy Industry
North America is predicted to hold a considerable market share in the global cancer immunotherapy industry. This surge can be attributed to the increased adoption of cancer immunotherapy in the region. In addition, the growing prevalence of cancer in the region has enhanced the demand for immunotherapies. According to the statistics given by National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors reported in the United States. Further, the number of cancer survivors is projected to increase to 22.2 million by 2030. These factors are estimated to drive the market growth in the region.
Cancer Immunotherapy: Market Segmentation
Cancer refers to diseases that can originate in any organ or tissue of the body where abnormal cells grow unnaturally and go beyond their usual boundaries to invade nearby body parts, also known as metastasizing. According to WHO, cancer is the second leading cause of death globally. Among men, lung, prostate, colorectal, stomach, and liver cancer are the most common types of cancer. In contrast, breast, colorectal, lung, cervical and thyroid cancer are the most common cancer types among women. In this regard, immunotherapy is a treatment for cancer that helps and supports a patient's immune system to fight cancer by providing a boost to the immune system's natural defences to locate and attack cancer cells in the body.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By therapy type, the market is distributed into:
- Monoclonal Antibodies
- Cancer Vaccines
- Immunomodulators
- Immune Check Point Inhibitors
- Others
On the basis of application, the industry can be categorised into:
- Prostate Cancer
- Breast Cancer
- Skin Cancer
- Lung Cancer
- Others
Based on end use, the market can be segmented into:
- Hospitals and Clinics
- Cancer Research Centres
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Heightened Prevalence of Cancer to Augment the Growth of the Global Cancer Immunotherapy Industry
According to the WHO statistics, cancer is the second leading cause of death globally, with around 9.6 million casualties reported in 2018. In 2020, the number of cancer cases reported was 19.3 million, and this number is estimated to rise to 30.2 million by 2040. Among these, the most commonly found cancer is breast cancer. In 2020, an estimated 2.3 million women were diagnosed with breast cancer and 685 000 deaths globally. Observing the growing prevalence of cancer worldwide, governments and international organisations are increasingly devising strategies and conceptualising initiatives to raise funds and awareness about cancer and its potential prevention. For instance, the WHO initiative, Global Breast Cancer Initiative (GBCI), aims to reduce the mortality rate by 2.5% every year, which would help to prevent 40% of cancer deaths by 2040. Their main objectives include health promotion for early detection, timely diagnosis, and comprehensive breast cancer management. Such developments are expected to drive market growth in the forecast period.
Key Industry Players in the Global Cancer Immunotherapy Market
The report gives a detailed analysis of the following key players in the global cancer immunotherapy market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Amgen Inc.
- Astellas Pharma Inc.
- AstraZeneca plc
- Bayer AG
- Bristol-Myers Squibb Company
- F. Hoffmann-La Roche AG
- Others
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Therapy Type, Application, End Use, Region |
| Breakup by Therapy Type | Monoclonal Antibodies, Cancer Vaccines, Immunomodulators, Immune Check Point Inhibitors, Others |
| Breakup by Application | Prostate Cancer, Breast Cancer, Skin Cancer, Lung Cancer, Others |
| Breakup by End Use | Hospitals and Clinics, Cancer Research Centres, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Amgen Inc., Astellas Pharma Inc., AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Cancer Immunotherapy Market Analysis
8.1 Key Industry Highlights
8.2 Global Cancer Immunotherapy Historical Market (2018-2022)
8.3 Global Cancer Immunotherapy Market Forecast (2023-2028)
8.4 Global Cancer Immunotherapy Market by Therapy Type
8.4.1 Monoclonal Antibodies
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Cancer Vaccines
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Immunomodulators
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.4.4 Immune Check Point Inhibitors
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2018-2022)
8.4.4.3 Forecast Trend (2023-2028)
8.4.5 Others
8.5 Global Cancer Immunotherapy Market by Application
8.5.1 Prostate Cancer
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Breast Cancer
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Skin Cancer
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.4 Lung Cancer
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2018-2022)
8.5.4.3 Forecast Trend (2023-2028)
8.5.5 Others
8.6 Global Cancer Immunotherapy Market by End Use
8.6.1 Hospitals and Clinics
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Cancer Research Centres
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Others
8.7 Global Cancer Immunotherapy Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2022)
9.5.2 Forecast Trend (2023-2028)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Amgen Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Astellas Pharma Inc.
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 AstraZeneca plc
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Bayer AG
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Bristol-Myers Squibb Company
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 F. Hoffmann-La Roche AG
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Cancer Immunotherapy Market: Key Industry Highlights, 2018 and 2028
2. Global Cancer Immunotherapy Historical Market: Breakup by Therapy Type (USD Million), 2018-2022
3. Global Cancer Immunotherapy Market Forecast: Breakup by Therapy Type (USD Million), 2023-2028
4. Global Cancer Immunotherapy Historical Market: Breakup by Application (USD Million), 2018-2022
5. Global Cancer Immunotherapy Market Forecast: Breakup by Application (USD Million), 2023-2028
6. Global Cancer Immunotherapy Historical Market: Breakup by End-Use (USD Million), 2018-2022
7. Global Cancer Immunotherapy Market Forecast: Breakup by End-Use (USD Million), 2023-2028
8. Global Cancer Immunotherapy Historical Market: Breakup by Region (USD Million), 2018-2022
9. Global Cancer Immunotherapy Market Forecast: Breakup by Region (USD Million), 2023-2028
10. North America Cancer Immunotherapy Historical Market: Breakup by Country (USD Million), 2018-2022
11. North America Cancer Immunotherapy Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Europe Cancer Immunotherapy Historical Market: Breakup by Country (USD Million), 2018-2022
13. Europe Cancer Immunotherapy Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Asia Pacific Cancer Immunotherapy Historical Market: Breakup by Country (USD Million), 2018-2022
15. Asia Pacific Cancer Immunotherapy Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Latin America Cancer Immunotherapy Historical Market: Breakup by Country (USD Million), 2018-2022
17. Latin America Cancer Immunotherapy Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Middle East and Africa Cancer Immunotherapy Historical Market: Breakup by Country (USD Million), 2018-2022
19. Middle East and Africa Cancer Immunotherapy Market Forecast: Breakup by Country (USD Million), 2023-2028
20. Global Cancer Immunotherapy Market Structure
Key Questions Answered in the Report
In 2020, the global cancer immunotherapy market attained a value of nearly USD 86,607 million.
The market is projected to grow at a CAGR of 9.7% between 2023 and 2028.
The major drivers of the industry include rapidly growing geriatric global population, rising numbers of casualties of different cancer varieties, increased adoption of cancer immunotherapy and heightened implementation of monoclonal antibodies therapy in cancer treatment.
The key market trends guiding the industry's growth include the growing prevalence of cancer worldwide and government initiatives to raise funds and awareness about cancer and its potential prevention.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The market is divided based on therapy type into monoclonal antibodies, cancer vaccines, immunomodulators, and immune check point inhibitors, among others.
The significant applications include into prostate cancer, breast cancer, skin cancer, and lung cancer, among others.
The significant segments based on end-use include hospitals and clinics and cancer research centres, among others.
The major players in the industry are Amgen Inc., Astellas Pharma Inc., AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, and F. Hoffmann-La Roche AG., among others.
Analyst Review
The global cancer immunotherapy market attained a value of USD 86,607 million in 2020, driven by the increased prevalence of cancer worldwide. Aided by heightened technological advancements and government initiatives to raise funds and awareness about cancer and its potential prevention, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 9.7%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By therapy type, the market can be distributed into monoclonal antibodies, cancer vaccines, immunomodulators, and immune check point inhibitors, among others. On the basis of application, the industry can be segmented into prostate cancer, breast cancer, skin cancer, and lung cancer, among others. Based on end-use, the industry can be segregated into hospitals and clinics and cancer research centres, among others. The major regional markets for the cancer immunotherapy are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Amgen Inc., Astellas Pharma Inc., AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, and F. Hoffmann-La Roche AG., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2799-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER